Perspectives on the developmental and reproductive toxicity guidelines

Developmental and Reproductive Toxicology: A Practical Approach

Volumn , Issue , 2005, Pages 733-798

  Christian, Mildred S ^a   Hoberman, Alan M ^a   Lewis, Elise M ^a  

^a Argus Research Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85123817058     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (98)

1. International Conference on Harmonisation (ICH) Harmonised Tripartite Guideline, Detection of toxicity to reproduction for medicinal products (proposed rule endorsed by the ICH Steering Committee at Step 4 of the ICH Process, 24 June 1993), in Proceedings of the Second International Conference on Harmonization, D'Arcy, P.F. and Harron, D.W.G., Eds., Greystone Books, Ltd. Antrim, N. Ireland, 1993, p. 557.
2. U.S. Food and Drug Administration, International Conference on Harmonisation, Guideline on detection of toxicity to reproduction for medicinal products, Fed. Regist., 59(183), 1994.
3. U.S. Food and Drug Administration, International Conference on Harmonisation, Guideline on detection of toxicity to reproduction for medicinal products, Addendum on toxicity to male fertility, Fed. Regist, 61(67), April 5, 1996.
4. U.S. Food and Drug Administration, International Conference on Harmonisation, Maintenance of the ICH Guideline on Toxicity to Male Fertility, An addendum to the ICH tripartite guideline on detection of toxicity to reproduction for medicinal products, amended November 9, 2000.
5. U.S. Food and Drug Administration, Guidelines for Reproduction Studies for Safety Evaluation of Drugs for Human Use, 1966.
6. U.S. Food and Drug Administration, Draft: Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives Used in Food (Red Book II), Guidelines for Reproduction and Developmental Toxicity Studies, Center for Food Safety and Applied Nutrition, Washington, DC, 1993, p. 123.
7. Christian, M.S. and Voytek, P.E., In vivo reproductive and mutagenicity tests, in A Guide to General Toxicology, Homburger, F., Hayes, J.A., and Pelikan, E.W., Eds., Karger, Basel, Switzerland, 1982, p. 294.
8. U.S. Environmental Protection Agency, Subpart E - specific organ/tissue toxicity, No. 798.4900: developmental toxicity study, 40 CFR Part 798, Toxic Substances Control Act test guidelines, final rules, Fed. Regist. 50:39433-39434, 1985a.
9. U.S. Environmental Protection Agency, Subpart E - specific organ/tissue toxicity, No. 798.4700: reproduction and fertility effects, 40 CFR Part 798, Toxic Substances Control Act test guidelines, final rules, Fed. Regist., 50:39432-39433, 1985b.
10. U.S. Environmental Protection Agency, Toxic Substances Control Act Test Guidelines (TSCA), (OPPTS-42193: FRL-5719-5), Final rule, 40 CFR Part 799, 1997.
11. U.S. Environmental Protection Agency (EPA-FIFRA), Hazard Evaluation Division Standard Evaluation Procedure: Teratology Studies, Office of Pesticide Programs, Washington, DC, EPA-540/9-85-018, 1985.
12. U.S. Environmental Protection Agency (EPA-FIFRA), Pesticide Assessment Guideline, Subdivision F - Hazard Evaluation: Human and Domestic Animals, Addendum 10: Neurotoxicity, Health Effects Division, Office of Pesticide Programs, March 1991.
13. U.S. Environmental Protection Agency (EPA-FIFRA), Health Effects Division Draft Standard Evaluation Procedure, Developmental Toxicity Studies, Office of Pesticides Programs, Washington, DC, 1993.
14. Committee on the Safety of Medicines, Notes for Guidance on Reproduction Studies, Department of Health and Social Security, Great Britain, 1974.
15. European Economic Community, The rules of governing medicinal products in the European Community, in Guidelines on the Quality, Safety and Efficacy of Medicinal Products for Human Use, Vol. III, Office of Official Publications of the European Communities, Brussels, 1988.
16. Ministry of Health and Welfare, Japan, On Animal Experimental Methods for Testing the Effects of Drugs on Reproduction, Notification No. 529 of the Pharmaceutical Affairs Bureau, Ministry of Health and Welfare, March 31, 1975.
17. Ministry of Health and Welfare, Japan, Information on the Guidelines of Toxicity Studies Required for Applications for Approval to Manufacture (Import) Drugs, Notification No. 118 of the Pharmaceutical Affairs Bureau, Ministry of Health and Welfare, February 15, 1984.
18. Tanimura, T., Kameyama, Y., Shiota, K., Tanaka, S., Matsumoto, N., and Mizutani, M., Report on the Review of the Guidelines for Studies of the Effect of Drugs on Reproduction, Notification No. 118, Pharmaceutical Affairs Bureau, Ministry of Health and Welfare, Japan, 1989.
19. International Conference on Harmonisation (ICH) Harmonised Tripartite Guideline, Male fertility studies in reproductive toxicology, in Proceedings of the Third International Conference on Harmonization, D'Arcy, P.F. and Harron, D.W.G., Eds., Greystone Books, Ltd., Antrim, N. Ireland, 1995, p. 245.
20. U.S. Food and Drug Administration, Toxicological Principles and Procedures for Priority Based Assessment of Food Additives (Red Book), Guidelines for Reproduction Testing with a Teratology Phase, Bureau of Foods, Washington, DC, 1982, p. 80.
21. U.S. Food and Drug Administration, Toxicological Principles for the Safety of Food Ingredients (Red Book 2000), Sections issued electronically July 7, 2000 at http://vm.cfscan.fda.gov/~Redbook/Red-tcct.html, 2000.
22. U.S. Environmental Protection Agency, Health Effects Test Guidelines: Prenatal Developmental Toxicity Study, Office of Prevention, Pesticides and Toxic Substances (OPPTS) 870.3700, 1998.
23. U.S. Environmental Protection Agency, Health Effects Test Guidelines: Reproduction and Fertility Effects, Office of Prevention, Pesticides and Toxic Substances (OPPTS) 870.3800, 1998.
24. U.S. Environmental Protection Agency, Health Effects Test Guidelines: Developmental Neurotoxicity Study, Office of Prevention, Pesticides and Toxic Substances (OPPTS) 870.6300, 1998.
25. U.S. Environmental Protection Agency (EPA-Risk Assessment Forum), Guidelines for developmental toxicity risk assessment, Fed. Regist., 56(234): 63798-63826, Dec. 5, 1991.
26. U.S. Environmental Protection Agency, Guidelines for Reproductive Toxicity Risk Assessment, NTIS PB No. PB97-100098, 1996a.
27. Organization for Economic Cooperation and Development, Guidelines for Testing of Chemicals, Section 4, No. 414: Teratogenicity, adopted 22 January 2001.
28. Organization for Economic Cooperation and Development, OECD Guidelines for Testing of Chemicals, Section 4, No. 415: One-Generation Reproduction Toxicity, adopted 26 May 1983.
29. Organization for Economic Cooperation and Development, OECD Guidelines for Testing of Chemicals, Section 4, No. 415: Two-Generation Reproduction Toxicity, adopted 22 January 2001(b).
30. Organization for Economic Cooperation and Development, OECD Guidelines for Testing of Chemicals, Section 4, No. 422: Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test, adopted 22 March 1996.
31. Organization for Economic Cooperation and Development, OECD Guidelines for Testing of Chemicals, Section 4, No. 426: Developmental Neurotoxicity Study, drafted October 1999.
32. Lenz, W. Kindliche micebildungen nach medikament wahrend der draviditat? Deutsch. Med. Wochenschr., 86, 2555, 1961.
33. McBride, W.G., Thalidomide and congenital abnormalities, Lancet, 2, 1358, 1961.
34. Herbst, A.L., Ulfelder, H., Poskanzer, D.C., Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women, New Engl. J. Med., 284, 878, 1971.
35. Koos, B.J. and Longo, L., Mercury toxicity in pregnant women, fetus and newborn infant, Am. J. Obstet. Gynecol., 126, 390, 1976.
36. Christian M.S. and Hoberman A.M., Perspectives on the U.S., EEC, and Japanese developmental toxicity testing guidelines, in Handbook of Developmental Toxicology, Hood, R.D., Ed., CRL Press, Inc., New York, 1997, p. 551.
37. U.S. Food and Drug Administration, 1998 Final Rule: Pediatric Studies, adopted April 1, 1999.
38. U.S. Environmental Protection Agency, Executive Order: Protection of Children from Environmental Health Risks and Safety Risks, available at http://www.epa.gov/children/whatwe/executiv.htm (verified 11 June 2002).
39. U.S. Food and Drug Administration, Food Quality Protection Act (FQPA): Public Law 104-170, 1996a.
40. U.S. Environmental Protection Agency, Safe Drinking Water Act. (SDWA): Public Law 104-182, 1996b.
41. U.S. Environmental Protection Agency, Endocrine Disruptor Screening Program, available at http://www.epa.gov/scipoly/oscpendo/index.htm (verified 11 June 2002).
42. Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC), EDSTAC Final Report, Compilation of EDSTAC Recommendations, chap. 7, available at http://www.epa.gov/sci-poly/oscpendo/history/chap7v14.pdf (verified 11 June 2002).
43. U.S. Environmental Protection Agency, Endocrine disruptor screening program: statement of policy notice, Fed. Regist., 63(248): 71541-71568, available at http://www.epa.gov/scipoly/oscpendo/fr122898_1.pdf (verified 11 June 2002).
44. U.S. Environmental Protection Agency, Endocrine Disruptor Method Validation Subcommittee under the National Advisory Council for Environmental Policy and Technology, Fed. Regist., 66(197): 51951-51952, available at http://www.epa.gov/oscpmont/oscpendo/fedregnotice.htm (verified 11 June 2002).
45. Research Triangle Institute, Draft Protocol: One-Generation Extension Study of Vinclozolin and din-butyl Phthalate Administered by Gavage on Gestational Day 6 to Postnatal Day 21 in CD® (Sprague-Dawley) Rats, Study No. RTA-ED01, Research Triangle Institute, Research Triangle Park, NC, for the US EPA, 2001.
46. Endocrine Disruptor Screening and Testing Advisory Committee, Male 20-day thyroid/pubertal assay in rodents, EDSTAC Final Report 1:5-30, 1998.
47. Endocrine Disruptor Screening and Testing Advisory Committee, Female 20-day thyroid/pubertal assay in rodents, EDSTAC Final Report 1:5-26, 1998.
48. Endocrine Disruptor Screening and Testing Advisory Committee, EDSTAC Final Report, Chap. 5, Appendix L, Protocols for Tier 1 screening assays, available at http://www.epa.gov/scipoly/oscpendo/history/app-lv14.pdf (verified 11 June 2002).
49. Organization for Economic Cooperation and Development, OECD Guidelines for Testing of Chemicals, Section 4, No. 407: Repeated Dose 28-Day Oral Toxicity Study in Rodents, adopted 27 July 1995.
50. Interagency Regulatory Group, Recommended Guideline for Teratogenicity Studies in the Rat, Mouse, Hamster or Rabbit, 1980.
51. Christian, M.S., Harmonization of reproductive guidelines: a perspective from the International Federation of Teratology Societies, J. Am. Coll. Toxicol, 11(3), 299, 1993.
52. D'Arcy, P.F. and Harron, D.W.G., Eds., Topic 2: Reproductive toxicology, in Proceedings of the First International Conference on Harmonisation, The Queen's University of Belfast, Belfast, Ireland, 1992, p. 255.
53. Organization for Economic Cooperation and Development (OECD), Final report - OECD short-term and long-term toxicology groups, Teratogenicity, 110, 1979.
54. U.S. Environmental Protection Agency, Harmonization and Regulatory Coordination: OECD Pesticide Working Group, available at http://www.epa.gov/oppfead1/international/harmonization.html (verified 18 June 2002).
55. U.S. Environmental Protection Agency, Federal Insecticide, Fungicide, and Rodenticide Act: 7 U.S.C. s/s 136 et seq., available at http://www4.law.cornell.edu/uscode/7/ch6.html (verified 18 June 2002).
56. U.S. Food and Drug Administration, The Federal Food, Drug and Cosmetic Act: §408, 21 U.S.C. 348a.
57. U.S. Environmental Protection Agency, About the Office of Pesticide Programs (OPP), available at http://www.epa.gov/pesticides/about.htm (verified 18 June 2002).
58. U.S. Environmental Protection Agency, About OPPT, available at http://www.epa.gov/oppt/opptabt.htm (verified 18 June, 2002).
59. U.S. Environmental Protection Agency, Toxic Substance Control Act (TSCA): 15 U.S.C. s/s 2601 et seq., available at http://www4.law.cornell.edu/uscode/15/ch53.html (verified 18 June 2002).
60. U.S. Environmental Protection Agency, About Harmonized Test Guidelines, available at http://epa.gov/docs/OPPTS_Harmonized/abguide.txt.html (verified 18 June 2002).
61. PMA guidelines, in Reproduction, Teratology and Pediatrics. Christian, M., Diener, R., Hoar, R., and Staples, R, Eds., 1981 (revised).
62. Sullivan, F.M., Behavioral teratology, in Proc. 11th Conf. of the European Teratology Society, Paris, 1983.
63. Christian, M.S., Postnatal alterations of gastrointestinal physiology, hematology, clinical chemistry, and other non-CNS parameters, in Handbook of Experimental Pharmacology: Teratogenesis and Reproductive Toxicology, Vol. 65, Springer, Berlin, 1983, p. 263.
64. Canada, Bureau of Drugs, Health Protection Branch, Health and Welfare, Draft of Preclinical Txicologic Guidelines, Section 2.4, 35, 1979.
65. Drug directorate guidelines, Toxicological Evaluation 2.4, Reproductive Studies, Ministry of National Health and Welfare, Health Protection Branch, Health and Welfare, Canada, 1990.
66. Somers, G.F, Letter to the editor, Lancet, 1, 912, 1962.
67. Wilson, J.G., Principles of teratology, in Environment and Birth Defects, Academic Press, New York, 1973, p. 11.
68. Palmer, A.K., Some thoughts on reproductive studies for safety evaluations, Proc. Europ. Soc. Study Drug Tox, 14, 79, 1973.
69. Johnson, E.M. and Christian, M.S., When is a teratology study not an evaluation of teratogenicity? J. Am. Coll. Toxicol., 3, 431, 1984.
70. Wilson, J.G., Methods for administering agents and detecting malformations in experimental animals, Teratology, Principles and Techniques, University of Chicago Press, Chicago, 1965, p. 262.
71. Staples, R.E., Detection of visceral alterations in mammalian fetuses, Teratology, 9, 37, 1974.
72. Christian, M.S., Test methods for assessing female reproductive and developmental toxicology, in Principles and Methods of Toxicology, Hayes, A.W., Ed., Taylor and Francis, Philadelphia, 2001, p. 1301.
73. Stuckhardt and Poppe, Fresh visceral examination of rat and rabbit fetuses used in teratogenicity testing, Teratogenesis, Carcinogenesis and Mutagenesis, 4, 181, 1984.
74. Staples, R.E. and Schnell, J.L., Refinement in rapid clearing technique in the KOH-alizarin red S method for fetal bone, Stain. Technol., 39, 61, 1963.
75. Peters, P.W.J., Double staining of fetal skeletons for cartilage and bone, in Methods in Prenatal Toxicology, Neubert, D., Merker, W.G., and Kwasigroch, T.E., Eds., Georg Thieme Publ., Stuttgart, 1977, p.153.
76. Whitaker, J. and Dix, K.M., Double staining technique for rat foetus skeletons in teratological studies, Lab. Animals, 13:309, 1979.
77. Webb G.N. and Byrd R.A., Simultaneous differential staining of cartilage and bone in rodent fetuses: an alcian blue and alizarin red S procedure without glacial acetic acid, Biotech Histochem, 69:181, 1994.
78. U.S. Environmental Protection Agency, Health Effects Test Guidelines: Combined Repeated Dose Toxicity with the Reproduction/Developmental Toxicity Screening Test, Office of Prevention, Pesticides and Toxic Substances (OPPTS) 870.3650, 2000.
79. Johnson, E.M., The scientific basis for multigeneration safety evaluation, J. Am. Coll. Toxicol, 5(4), 197, 1986.
80. Christian, M.S., A critical review of multigeneration studies, J. Am. Coll. Toxicol., 5(2), 161, 1986.
81. U.S. Food and Drug Administration, Good Laboratory Practice Regulations, Final Rule 21, Code of Federal Regulations, Part 58.
82. Organization for Economic Cooperation and Development, Laboratory Practice in the Testing of Chemicals, Final Rule of the OCED Expert Group on Laboratory Practices [C(81) 3.0 (Final), Annex 2], 1981.
83. Japanese Ministry of Agriculture, Forestry and Fisheries (MAFF), Good Laboratory Practice Regulations, 59 Noshan No. 3850, 1984.
84. U.S. Environmental Protection Agency, Federal Insecticide, Fungicide and Rodenticide Act (EPAFIFRA), Good Laboratory Practice Standards, Final Rule, 40 CFR Part 160.
85. U.S. Environmental Protection Agency, Toxic Substances Control Act, Good Laboratory Practice Standards, Final Rule, 40 CFR Part 792.
86. Christian, M.S., The use of CASA systems for reproductive toxicology (CRYO Resources Ltd. CellSoft Series 4000 Tox. System vs the Hamilton Thorne HTM-IVOS), presented at the 82nd Meeting of the Mid-Atlantic Reproduction and Teratology Association, Lambertville, PA, October 14-15, 1993.
87. Christian, M.S., Compliance with tripartite guideline for male reproductive performance, presented at the Pharmaceutical Manufacturers Association Drug Safety Subsection Annual Meeting, Austin, TX, October 17-20, 1993c.
88. Plowchalk, D.R. and Mattison, D.R., Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide, Toxicol. Appl. Pharmacol, 107, 472, 1991.
89. Smith, B.J., Plowchalk, D.R., Sipes, I.G., and Mattison, D.R., Comparison of random and serial sections in assessment of ovarian toxicity, Reprod. Toxicol., 5, 379, 1991.
90. Plowchalk, D.R., Smith, B.J., and Mattison, D.R., Assessment of toxicity to the ovary using follicle quantitation and morphometrics, in Methods In Toxicology, Vol. 3B, Female Reproductive Toxicology, Heindel, J.J. and Chapin, R.E., Eds., Academic Press, San Diego, 1993, p. 57.
91. Christian, M.S. and Brown W.R., Control primordial follicle counts in multigeneration studies in CRL Sprague-Dawley ("Gold Standard") rats, The Toxicologist, 66(1S), A1140, 2002.
92. U.S. Environmental Protection Agency, Proposed Testing Guidelines, Notice of Availability and Request for Comments, 61 FR 31522, 1996c.
93. U.S. Environmental Protection Agency, Overview and Summary of Changes Made in the Harmonization of OPPTS 870 Toxicology Guidelines with OECD Guidelines, available at http://www.epa.gov/docs/OPPTS_Harmonized/870_Health_Effects_Test_Guidelines/Summary/summchge.htm (verified 18 June 2002).
94. Palmer, A.K. and Ulbrich, B.C., The cult of culling, Fund. Applied Toxicol., 38, 7, 1997.
95. Diener, R.M., Timing and utility of behavioral studies in developmental toxicology, in Proceedings of the First International Conference on Harmonisation, D'Arcy P.F. and Harron, D.W.G., Eds., The Queen's University of Belfast, Antrim, Northern Ireland, 1993, p. 273.
96. Lochry, E.A. and Christian, M.S., Behavioral evaluations in reproductive safety assessments, J. Am. Coll. Toxicol., 10(5), 585, 1991.
97. Lewis, E.M., Barnett Jr., J.F., Freshwater, L., Hoberman, A.M., and Christian, M.S., Sexual maturation data for Crl Sprague-Dawley rats: criteria and confounding factors, Drug Chem. Toxicol., 2002.
98. Endocrine Disruptor Screening and Testing Advisory Committee, EDSTAC final report, available at http://http://www.epa.gov/scipoly/oscpendo/history/finalrpt.htm (verified 11 June 2002).